Zhengye Biotechnology Holding Stock Today

ZYBT Stock   4.99  0.05  1.01%   

Performance

Insignificant

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Zhengye Biotechnology is selling for under 4.99 as of the 16th of February 2025; that is 1.01 percent up since the beginning of the trading day. The stock's last reported lowest price was 4.71. Zhengye Biotechnology has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 16th of February 2025. Click here to learn more.
IPO Date
7th of January 2025
Category
Healthcare
Zhengye Biotechnology is entity of United States. It is traded as Stock on NASDAQ exchange. More on Zhengye Biotechnology Holding

Moving against Zhengye Stock

  0.81HROWM Harrow Health, 11875PairCorr
  0.76PROCW Procaps Group SAPairCorr
  0.73YCBD-PA cbdMD IncPairCorr
  0.71DWTX Dogwood Therapeutics, Symbol ChangePairCorr
  0.69BDMDW Baird Medical InvestmentPairCorr
  0.68TLX Telix PharmaceuticalsPairCorr

Zhengye Stock Highlights

Business ConcentrationPharmaceutical Products, Drug Manufacturers - Specialty & Generic, Healthcare, NASDAQ Composite, NASDAQ Health Care, Biotechnology, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Net Debt56.3 M86 M
Way Down
Slightly volatile
Total Current Liabilities157 M172.8 M
Moderately Down
Slightly volatile
Non Current Liabilities TotalM11.9 M
Way Down
Slightly volatile
Total Assets537.1 M574.9 M
Significantly Down
Slightly volatile
Total Current Assets214.4 M236.4 M
Moderately Down
Slightly volatile
Total Cash From Operating Activities35.7 M55.4 M
Way Down
Slightly volatile
Zhengye Biotechnology can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Zhengye Biotechnology's financial leverage. It provides some insight into what part of Zhengye Biotechnology's total assets is financed by creditors.
100%
100%
Non Current Assets Total58.18%Total Current Assets38.66%I...100%
Liquidity
Zhengye Biotechnology Holding currently holds 79.86 M in liabilities. Note, when we think about Zhengye Biotechnology's use of debt, we should always consider it together with its cash and equity.

Capital Expenditures

17.42 Million
27.311.610.417.4-58%-10%67%100%
Zhengye Biotechnology Holding (ZYBT) is traded on NASDAQ Exchange in USA. It is located in No.1 Lianmeng Road, Jilin, China, 132101 and employs 278 people. Zhengye Biotechnology is listed under Pharmaceutical Products category by Fama And French industry classification. The company conducts business under Healthcare sector and is part of Biotechnology industry.
Check Zhengye Biotechnology Probability Of Bankruptcy

Zhengye Biotechnology Historical Income Statement

At this time, Zhengye Biotechnology's Gross Profit is comparatively stable compared to the past year. Net Income From Continuing Ops is likely to gain to about 37.3 M in 2025, whereas Interest Income is likely to drop slightly above 197.3 K in 2025. View More Fundamentals

Zhengye Stock Against Markets

Zhengye Biotechnology Corporate Management

Wei LianVice ManagerProfile
Yuyou HeVice ManagerProfile
Ping WangChief OfficerProfile
Zhongyao LiuChief OfficerProfile
Yuhong ChengVice ManagerProfile
Songlin SongChief OfficerProfile

Already Invested in Zhengye Biotechnology Holding?

The danger of trading Zhengye Biotechnology Holding is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zhengye Biotechnology is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zhengye Biotechnology. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zhengye Biotechnology is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Tools for Zhengye Stock Analysis

When running Zhengye Biotechnology's price analysis, check to measure Zhengye Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhengye Biotechnology is operating at the current time. Most of Zhengye Biotechnology's value examination focuses on studying past and present price action to predict the probability of Zhengye Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhengye Biotechnology's price. Additionally, you may evaluate how the addition of Zhengye Biotechnology to your portfolios can decrease your overall portfolio volatility.

Discover investing ideas

Utilize additional investing modules